Within-session analysis of amphetamine-elicited rotation behavior reveals differences between young adult and middle-aged F344/BN rats with partial unilateral striatal dopamine depletion

Pharmacology Biochemistry and Behavior

Volumn 96, Issue 4, 2010, Pages 423-428

  Bethel Brown, Crystal S ^a   Zhang, Hongyu ^b   Fowler, Stephen C ^b,c   Chertoff, Mark E ^b   Watson, G Stennis ^d   Stanford, John A ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF KANSAS   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Animal models; Basal ganglia; Behavioral assay; Parkinson's disease; Rotation; Striatum

Indexed keywords

AMPHETAMINE; OXIDOPAMINE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BLOOD LEVEL; DOPAMINE RELEASE; DRUG INDUCED DISEASE; GROUPS BY AGE; LOCOMOTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REGRESSION ANALYSIS; ROTATION; TASK PERFORMANCE;

3,4-DIHYDROXYPHENYLACETIC ACID; AGE FACTORS; AMPHETAMINES; ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DOPAMINE; OXIDOPAMINE; RATS; RATS, INBRED F344;

ANIMALIA; RATTUS;

EID: 77956060631     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.06.014     Document Type: Article

References (42)

1. Barneoud P., Descombris E., Aubin N., Aubrous D.N. Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system. Eur J Neurosci 2000, 12:322-336.
2. Barnéoud P., Parmentier S., Mazadier M., Miquet J.M., Boireau A., Dubédat P., Blanchard J.C. Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat. Neuroscience 1995, 67:837-848.
3. Bergstrom B.P., Garris P.A. 'Passive stabilization' of striatal extracellular dopamine across the lesion spectrum encompassing the presymptomatic phase of Parkinson's disease: a voltammetric study in the 6-OHDA-lesioned rat. J Neurochem 2003, 87:1224-1236.
4. Bjorklund A., Rosenblad C., Winkler C., Kirik D. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol Dis 1997, 4:186-200.
5. Blandini F., Levandis G., Bazzini E., Nappi G., Armentero M.T. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model. Eur J Neurosci 2007, 25:397-405.
6. Bolam J.P., Hanley J.J., Booth P.A.C., Bevan M.D. Synaptic organisation of the basal ganglia. J Anat 2000, 196:527-542.
7. Cass W.A., Harned M.E., Bailey S.L. Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats. Brain Res 2002, 938:29-37.
8. Cousins M.S., Salamone J.D. Involvement of ventrolateral striatal dopamine in movement initiation and execution: a microdialysis and behavioral investigation. Neuroscience 1996, 70:849-859.
9. Deumens R., Blokland A., Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol 2002, 175:303-317.
10. Enna S.J., Reisman S.A., Stanford J.A. CGP 56999A, a GABAB receptor antagonist, enhances expression of brain-derived neurotrophic factor and attenuates dopamine depletion in the rat corpus striatum following a 6-hydroxydopamine lesion of the nigrostriatal pathway. Neurosci Lett 2006, 406:102-106.
11. Fleming S.M., Delville Y., Schallert T. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate. Behav Brain Res 2005, 156:201-213.
12. Fowler S.C., Birkestrand B.R., Chen R., Moss S.J., Vorontsova E., Wang G., et al. A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Meth 2001, 107:107-124.
13. Gould T.J., Stromberg I., Bickford P.C. Decline in striatal dopamine D1 and D2 receptor activation in aged F344 rats. Neurobiol Aging 1996, 17:877-883.
14. Hauber W. Involvement of basal ganglia transmitter systems in movement initiation. Prog Neurobiol 1998, 56:507-540.
15. Hebert M.A., Gerhardt G.A. Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in Fischer 344 rats. Brain Res 1998, 797:42-54.
16. Hebert M.A., Gerhardt G.A. Age-related changes in the capacity, rate, and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 344 rats: an in vivo electrochemical study. J Pharmacol Exp Ther 1999, 288:879-887.
17. Hebert M.A., Larson G.A., Zahniser N.R., Gerhardt G.A. Age-related reductions in [3H]WIN 35, 428 binding to the dopamine transporter in nigrostriatal and mesolimbic brain regions of the Fischer 344 rat. J Pharmacol Exp Ther 1999, 288:1334-1339.
18. Hefti F., Melamed E., Sahakian B.J., Wurtman R.J. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and L-DOPA. Pharmacol Biochem Behav 1980, 12:185-188.
19. Hudson J.L., van Horne C.G., Stromberg I., Brock S., Clayton J., Masserano J., et al. Correlation of apomorphine- and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats. Brain Res 1993, 626:167-174.
20. Jackson E.A., Kelly P.H. Role of nigral dopamine in amphetamine-induced locomotor activity. Brain Res 1983, 278:366-369.
21. Kirik D., Rosenblad C., Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol 1998, 152:259-277.
22. Lindner M.D., Cain C.K., Plone M.A., Frydel B.R., Blaney T.J., Emerich D.F., et al. Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats. Behav Brain Res 1999, 102:1-16.
23. Marshall J.F., Drew M.C., Neve K.A. Recovery of function after mesotelencephalic dopaminergic injury in senescence. Brain Res 1983, 259:249-260.
24. National Research Council Guide for the care and use of laboratory animals 1996, National Academy Press, Washington, D.C.
25. Olds M.E., Jacques D.B., Kopyov O. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions. Synapse 2006, 59:532-544.
26. Robertson G.S., Robertson H.A. Evidence that L-dopa-induced rotational behaviour is dependent on both striatal and nigral mechanisms. J Neurosci 1989, 9:3326-3331.
27. Salvatore M.F., Gerhardt G.A., Dayton R.D., Klein R.L., Stanford J.A. Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system. Exp Neurol 2009, 219:197-207.
28. Sanchez-Iglesias S., Rey P., Mendez-Alvarez E., Labandeira-Garcia J.L., Soto-Otero R. Time-course of brain oxidative damage caused by intrastriatal administration of 6-hydroxydopamine in a rat model of Parkinson's disease. Neurochem Res 2007, 32:99-105.
29. Sauer H., Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 1994, 59:401-415.
30. Sharp T., Zetterstrom T., Ljungberg T., Ungerstedt U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res 1987, 401:322-330.
31. Stanford J.A., Gerhardt G.A. Age-related changes in striatal function of freely-moving F344 rats. Neurobiol Aging 2001, 22(4):659-669.
32. Stanford J.A., Hebert M.A., Gerhardt G.A. Biochemical and anatomical changes in basal ganglia of aging animals. Functional neurobiology of aging 2001, 727-735. Academic Press, San Diego. P.R. Hof, C.V. Mobbs (Eds.).
33. Stanford J.A., Gash C.R., Gerhardt G.A. Aged F344 rats exhibit an increased proportion of dopamine agonist-excited striatal neurons. Neurobiol Aging 2002, 23:263-270.
34. Stanford J.A., Salvatore M.F., Joyce B.M., Zhang H., Gash D.M., Gerhardt G.A. Bilateral effects of unilateral intrastriatal GDNF on locomotor-excited and nonlocomotor-related striatal neurons in aged F344 rats. Neurobiol Aging 2007, 28:156-165.
35. Truex L.L., Schmidt M.J. 3-H-amphetamine concentrations in the brains of young and aged rats: implications for assessment of drug effects in aged animals. Neurobiol Aging 1980, 1:93-95.
36. Ungerstedt U., Arbuthnott G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 1970, 24:485-493.
37. Whishaw I.Q., Woodward N.C., Miklyaeva E., Pellis S.M. Analysis of limb use by control rats and unilateral DA-depleted rats in the Montoya staircase test: movements, impairments and compensatory strategies. Behav Brain Res 1997, 89:167-177.
38. Yuan H., Sarre S., Ebinger G., Michotte Y. Histological, behavioural and neurochemical evaluation of medial forebrain bundle and striatal 6-OHDA lesions as rat models of Parkinson's disease. J Neurosci Meth 2005, 144:35-45.
39. Yurek D.M., Fletcher-Turner A. Lesion-induced increase of BDNF is greater in the striatum of young versus old rat brain. Exp Neurol 2001, 161:392-396.
40. Yurek D.M., Hipkens S.B., Hebert M.A., Gash D.M., Gerhardt G.A. Age-related decline in striatal dopamine release and motoric function in brown Norway/Fischer 344 hybrid rats. Brain Res 1998, 791:246-256.
41. Zigmond M.J. Do compensatory processes underlie the preclinical phase of neurodegenerative disease? Insights from an animal model of parkinsonism. Neurobiol Dis 1997, 4:247-253.
42. Zigmond M.J., Acheson A.L., Stachowiak M.K., Stricker E.M. Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. Arch Neurol 1984, 41:856-861.